Matrix Capital Management Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$768M |
| 2 |
Qualcomm
QCOM
|
+$146M |
| 3 |
Micron Technology
MU
|
+$142M |
| 4 |
Zillow
Z
|
+$97.2M |
| 5 |
DOCU
DocuSign
DOCU
|
+$93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.85% |
| 2 | Healthcare | 29.89% |
| 3 | Communication Services | 19.41% |
| 4 | Consumer Discretionary | 7.24% |
| 5 | Industrials | 5.52% |
Similar funds
Matrix Capital Management Company's Q2 2019 Portfolio in Review
As of Q2 2019, Matrix Capital Management Company held 25 positions worth $5.41B, up 44% from $3.75B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Matrix Capital Management Company deployed $1.36B of net new capital in Q2 2019, opening 5 new positions and adding to 5 existing holdings. Its largest new stake was Adaptive Biotechnologies: 17,332,191 shares worth $837M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the most notable exit was Teradyne, an estimated $19.9M sold.
- Matrix Capital Management Company's largest Q2 2019 buy was Adaptive Biotechnologies: 17,332,191 shares worth $837M.
- Matrix Capital Management Company added most to Micron Technology in Q2 2019, an estimated $142M increase.
- Matrix Capital Management Company fully exited Teradyne in Q2 2019, selling an estimated $19.9M.
- Matrix Capital Management Company's ten largest holdings make up 73% of its $5.41B portfolio in Q2 2019.
- Matrix Capital Management Company opened 5 new positions and closed 1 in Q2 2019.
- Matrix Capital Management Company's portfolio value rose 44% quarter-over-quarter to $5.41B.
Based on Matrix Capital Management Company's 13F filing for Q2 2019, filed 14 Aug 2019.